Paper30838514
Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke.
Yang M and 3 others. Drugs, 2019. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke. Papers, record 30838514. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30838514
- Disease
- ischemic stroke213 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Ischemia | Major topic |
| Platelet Aggregation Inhibitors | Major topic |
| Platelet Glycoprotein GPIIb-IIIa Complex | Major topic |
| Stroke | Major topic |
| Tirofiban | Major topic |
| Humans | |
| Platelet Aggregation | |
| Stroke Rehabilitation | |
| Thrombosis |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT07290751 | Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke | Background | ClinicalTrials.gov | |
| NCT07335107 | Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion | Results | ClinicalTrials.gov |
References114
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10436319 | Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. | Cerebrovasc Dis | 1999 | https://conductscience.org/library/papers/10436319 | PubMed |
| 2 | 10745462 | Therapeutic dissolution of an intracoronary thrombus by prolonged intravenous platelet glycoprotein IIb/IIIa antagonism. | J Invasive Cardiol | 1999 | https://conductscience.org/library/papers/10745462 | PubMed |
| 3 | 10834640 | Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I--Pathophysiological and pharmacological features. | Neurosurgery | 2000 | https://conductscience.org/library/papers/10834640 | PubMed |
| 4 | 10835463 | Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia. | Stroke | 2000 | https://conductscience.org/library/papers/10835463 | PubMed |
| 5 | 10880411 | Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions. | Circulation | 2000 | https://conductscience.org/library/papers/10880411 | PubMed |
| 6 | 11487034 | Anti-GPIIb/IIIa drugs: current strategies and future directions. | Thromb Haemost | 2001 | https://conductscience.org/library/papers/11487034 | PubMed |
| 7 | 11577835 | Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings. | Ital Heart J | 2001 | https://conductscience.org/library/papers/11577835 | PubMed |
| 8 | 11719681 | Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases. | Radiology | 2001 | https://conductscience.org/library/papers/11719681 | PubMed |
| 9 | 11721100 | Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study. | Cerebrovasc Dis | 2001 | https://conductscience.org/library/papers/11721100 | PubMed |
| 10 | 11823719 | Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy. | J Cereb Blood Flow Metab | 2002 | https://conductscience.org/library/papers/11823719 | PubMed |
| 11 | 11901016 | Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases. | AJNR Am J Neuroradiol | 2002 | https://conductscience.org/library/papers/11901016 | PubMed |
| 12 | 11919304 | Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. | N Engl J Med | 2002 | https://conductscience.org/library/papers/11919304 | PubMed |
| 13 | 11964126 | Glycoprotein IIb/IIIa antagonists--from bench to practice. | Cell Mol Life Sci | 2002 | https://conductscience.org/library/papers/11964126 | PubMed |
| 14 | 12052983 | Lacunar stroke is the major cause of progressive motor deficits. | Stroke | 2002 | https://conductscience.org/library/papers/12052983 | PubMed |
| 15 | 12083481 | An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates. | Thromb Haemost | 2002 | https://conductscience.org/library/papers/12083481 | PubMed |
| 16 | 12297567 | Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. | Neurology | 2002 | https://conductscience.org/library/papers/12297567 | PubMed |
| 17 | 12742983 | Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. | Circulation | 2003 | https://conductscience.org/library/papers/12742983 | PubMed |
| 18 | 12771267 | Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study. | Neurology | 2003 | https://conductscience.org/library/papers/12771267 | PubMed |
| 19 | 12829861 | Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations. | Stroke | 2003 | https://conductscience.org/library/papers/12829861 | PubMed |
| 20 | 14718754 | Progressing stroke: towards an internationally agreed definition. | Cerebrovasc Dis | 2004 | https://conductscience.org/library/papers/14718754 | PubMed |
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42839966 | Association of a platelet function testing-guided intensified antiplatelet strategy with thromboembolic events after EP2 stent-assisted coil embolization in patients with unruptured intracranial aneurysms. | Front Neurol | 2026 | https://conductscience.org/library/papers/42839966 | PubMed |
| 42780889 | Association between tirofiban administration and sex in outcomes following endovascular treatment for large vessel occlusion stroke. | Front Neurol | 2026 | https://conductscience.org/library/papers/42780889 | PubMed |
| 42666858 | Early antiplatelet therapy was associated with reduced neurological deterioration in stroke patients treated with intravenous thrombolysis. | Brain Circ | 2026 | https://conductscience.org/library/papers/42666858 | PubMed |
| 42646373 | Acute and Chronic Cerebral Hypoperfusion After Flow-Diverter Placement: Is There a Role for Extra-Intracranial Bypass? A Case Series and Narrative Literature Review. | Neurol Int | 2026 | https://conductscience.org/library/papers/42646373 | PubMed |
| 42432445 | Tirofiban Versus Alteplase for Patients With Minor Acute Ischemic Stroke: A Target Trial Emulation Study. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42432445 | PubMed |
| 42393539 | Association of low-dose intra-arterial plus intravenous tirofiban with improved functional outcome in branch atheromatous disease-related stroke patients with early neurological deterioration. | BMC Neurol | 2026 | https://conductscience.org/library/papers/42393539 | PubMed |
| 42315720 | Efficacy and safety of adjuvant tirofiban versus intravenous thrombolysis alone in acute ischemic stroke: an updated meta-analysis of randomized controlled trials. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42315720 | PubMed |
| 42315198 | Efficacy and safety of early tirofiban administration after intravenous thrombolysis in patients with acute ischaemic stroke: the multicentre, randomised, double-blind, placebo-controlled RESCUE BT3 trial protocol. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42315198 | PubMed |
| 42154376 | Uniform shear-induced platelet aggregation analysis via microfluidics fabricated from 3D-printed mold: a rapid platform for antiplatelet drug assessment. | Anal Sci | 2026 | https://conductscience.org/library/papers/42154376 | PubMed |
| 41995942 | Efficacy and safety of early intravenous administration of tirofiban after thrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/41995942 | PubMed |
| 41993645 | Tirofiban combined with aspirin for branch atheromatous disease: a propensity score-matched study. | Front Neurol | 2026 | https://conductscience.org/library/papers/41993645 | PubMed |
| 41882560 | Efficacy and Safety of tirofiban in acute ischemic stroke patients with early neurological deterioration: a meta-analysis. | BMC Neurol | 2026 | https://conductscience.org/library/papers/41882560 | PubMed |
| 41822823 | Assessment of No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Vessel. | Cardiol Res | 2026 | https://conductscience.org/library/papers/41822823 | PubMed |
| 41559328 | Impact of Prestroke Antiplatelet Therapy on the Efficacy of Intravenous Tirofiban at Preventing Early Neurological Deterioration: A Prespecified Subgroup Analysis of the TREND Trial. | Am J Cardiovasc Drugs | 2026 | https://conductscience.org/library/papers/41559328 | PubMed |
| 41553624 | Thrombolysis with Adjunctive Tirofiban in Acute Non-cardioembolic Posterior Circulation Ischemic Stroke: A Propensity Score-Matched Analysis. | Neurol Ther | 2026 | https://conductscience.org/library/papers/41553624 | PubMed |
| 41466170 | Adjunct tirofiban after intravenous thrombolysis in acute ischemic stroke: a GRADE-guided meta-analysis of randomized trials with trial sequential analysis. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/41466170 | PubMed |
| 41458952 | Real-world safety of tirofiban: a disproportionality analysis using data from FAERS and WHO-VigiAccess. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41458952 | PubMed |
| 41456941 | Tirofiban for Preventing Early Neurological Deterioration in Acute Ischemic Stroke Within 48 Hours of Onset: Evidence From a Dual-Method Analysis Using Propensity Score Matching and Multivariable Regression. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/41456941 | PubMed |
| 41427506 | Efficacy and safety of adjunctive tirofiban administration in anterior large vessel occlusion due to large artery atherosclerosis: an individual patient data pooled analysis of two randomized clinical trials. | Int J Surg | 2026 | https://conductscience.org/library/papers/41427506 | PubMed |
| 41326478 | High glucose enhances inflammation-driven platelet adhesion to endothelial cells in vitro. | Sci Rep | 2025 | https://conductscience.org/library/papers/41326478 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 |
Source NCBI Gene
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| TIROFIBAN | CHEMBL916 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL916 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30838514
GET https://conductscience.org/api/papers/v1/30838514/references?page=2